Category: Lifestyle Medicine; Technology (e.g. robotics, assistive technology, mHealth)
Objective : To establish safe use of a cooled compressive exercise technology in Type II Diabetics and to examine the effect of 3 months of training on biometabolic markers.
Design : Before-and-after Intervention Study
Setting : Primary Care
Participants (or Animals, Specimens, Cadavers) :
Volunteer Sample 16 Type II Diabetics in Covenant Medical Primary Care
Interventions : 1-2 sessions per week for three months on an exercise platform that combines 21-minute interval training on a recumbent bicycle with cooling (47o water on seat, footplates) and compression (liquid-compression applied bilaterally on biceps-triceps, 40mmHg, and quadriceps-hamstrings, 65mmHg).
Main Outcome Measure(s) : Biometabolic markers via blood draw were analyzed at 0 and 3 months, main outcomes focused on Glycohemoglobin and weight.
Data was analyzed with a two-tailed T-test, revealing significant differences in Glycohemoglobin and weight. There was an 8% average decrease in Glycohemoglobin levels (8.5±2.2 vs. 7.8±1.8 mg/dl, p = 0.002) and an average weight loss of 3.6 lbs (211±50 vs. 208±48 lbs, p = 0.032).
Conclusions : The preliminary results of this study suggest exercise with compression and cooling contributes to a reduction in biometabolic markers of diabetes. The most potent lifestyle intervention for treatment of Type II Diabetes is consistent exercise. However, for many with the condition, other comorbidities such as osteoarthritis, hypertension, and high body mass indexes prevent patients from being able to exercise intensively enough to experience optimal metabolic benefits. Recent research has supported the use of compression exercise in physically limited populations and demonstrated physiologic responses at lower intensities (10-20%). This intervention has promise in contributing to effective management of T2D with a low physical burden.